跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DECONGESTANT NASAL SPRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DECONGESTANT NASAL SPRAY
Authorized
STANDARD
DECONGESTANT NASAL SPRAY
crls
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6f1f33f8cd6793dc
Company
crls
Type
Standard
Approval Details
Approval Id
6f1f33f8cd6793dc
Drug Approval Canada Name
DECONGESTANT NASAL SPRAY
Product Name
DECONGESTANT NASAL SPRAY
Status
Marketed
Status Date
2017-03-07
Original Market Date
2017-03-07
Din
02452812
Drug Class
Human
Dosage Form
Spray
Route Of Administration
Nasal
Schedule
OTC
Ahfs
52:32.00
Atc Original
R01AA07 XYLOMETAZOLINE
Atc Name
r 01 aa 07
Aig Number
0107655001
Company Name
crls
Company Address
Suite 220, 2020 4 Street Sw, Calgary, Alberta, Canada, T2S 1W3
Active Ingredients
XYLOMETAZOLINE HYDROCHLORIDE
0.1 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6f1f33f8cd6793dc
Type
Standard
Back to Health Canada Approvals